|
| |
| | | 67141 | | 12.12.2019 | | Pfizer AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Talzenna 0.25 mg | Hartkapseln | Capsules (Talazoparibum 0.25 mg) | L01XK04 | CI | | 02 | Talzenna 1 mg | Hartkapseln | Capsules (Talazoparibum 1 mg) | L01XK04 | CI | | 03 | Talzenna 0.1 mg | Hartkapseln | Capsules (Talazoparibum 0.1 mg) | L01XK04 | CI | | 04 | Talzenna 0.35 mg | Hartkapseln | Capsules (Talazoparibum 0.35 mg) | L01XK04 | CI | | 05 | Talzenna 0.5 mg | Hartkapseln | Capsules (Talazoparibum 0.5 mg) | L01XK04 | CI |
|
|
|
